These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11354700)

  • 21. Live attenuated varicella vaccine: immunization of healthy children with the OKA strain.
    Arbeter AM; Starr SE; Weibel RE; Plotkin SA
    J Pediatr; 1982 Jun; 100(6):886-93. PubMed ID: 6283051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
    Ozaki T; Nishimura N; Kajita Y
    Vaccine; 2000 May; 18(22):2375-80. PubMed ID: 10738094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes zoster in three healthy children immunized with varicella vaccine (Oka/Biken); the causative virus differed from vaccine strain on PCR analysis of the IV variable region (R5) and of a PstI-site region.
    Na GY
    Br J Dermatol; 1997 Aug; 137(2):255-8. PubMed ID: 9292076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness over time of varicella vaccine.
    Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
    JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunology of Varicella Immunization in the elderly.
    Raeder CK; Hayney MS
    Ann Pharmacother; 2000 Feb; 34(2):228-34. PubMed ID: 10676831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees.
    Krause PR
    Arch Virol Suppl; 2001; (17):7-15. PubMed ID: 11339552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protective effect of vaccination against chickenpox].
    Plesník V; Príkazský V; Pĕtvaldská L
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):143-7. PubMed ID: 11188760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Aseptic Meningitis Without Skin Rash Caused by Oka Varicella Vaccine.
    Kawamura Y; Suzuki D; Kono T; Miura H; Kozawa K; Mizuno H; Yoshikawa T
    Pediatr Infect Dis J; 2022 Jan; 41(1):78-79. PubMed ID: 34591803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
    Armenian SH; Han JY; Dunaway TM; Church JA
    Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; Heywood A; McIntyre P
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.